Executive record
Faraz Ali, M.B.A.
Most recent record: Tenaya Therapeutics, Inc. CFO transition: Eric Hyllengren, M.B.A. to succeed Faraz Ali, M.B.A. (named as the outgoing officer), effective July 13, 2026.
2 verified records · 1 company
Career line from the records
2Each seat as a filing states it, newest first. Titles appear only as the filing prints them for this person.
2026-06-29TransitionTenaya Therapeutics, Inc.
Tenaya Therapeutics, Inc. CFO transition: Eric Hyllengren, M.B.A. to succeed Faraz Ali, M.B.A.Named as the outgoing officer
effective July 13, 2026 · 8-K filed June 29, 2026 · sec.gov, Item 5.02
2026-03-1110-K signatureTenaya Therapeutics, Inc.
Signed the annual report as Chief Executive Officer and Director (Principal Executive Officer and Interim Principal Financial Officer)
10-K filed March 11, 2026 · sec.gov
Companies
1This page lists only verified filing records that name Faraz Ali, M.B.A., matched by the name as the filings print it; it is not a career history. Corrections: the corrections page.